Clinical significance of anti-citrullinated peptide antibody in Japanese patients with established rheumatoid arthritis.
Nakamura
H
H
Kawakami
A
A
Ida
H
H
Origuchi
T
T
Matsuoka
N
N
Tsuboi
M
M
Furuyama
M
M
Mizokami
A
A
Tsukada
T
T
Nakashima
M
M
Ejima
E
E
Hamasaki
K
K
Aoyagi
K
K
Uetani
M
M
Fukuda
T
T
Honda
S
S
Urayama
S
S
Kawabe
Y
Y
Ueki
Y
Y
Mine
M
M
Eguchi
K
K
D001172:Arthritis, Rheumatoid / Q000276:immunology*; D001323:Autoantibodies / Q000097:blood*; D015415:Biomarkers; D006801:Humans; D007564:Japan; D020782:Matrix Metalloproteinases / Q000097:blood; D010456:Peptides, Cyclic / Q000276:immunology*; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity
D001323:Autoantibodies; D015415:Biomarkers; D010456:Peptides, Cyclic; C487763:cyclic citrullinated peptide; D020782:Matrix Metalloproteinases